In summary, while some patientsespecially those with sporadic, completely resected, and smaller tumorsmay achieve durable remission, malignant schwannoma remains a high-risk malignancy with limited curative options once it recurs or metastasizes
Serum levels of interleukin-6, interleukin-8, interleukin-10, and tumor necrosis factor-alpha, renal function biochemical parameters and clinical outcomes in pediatric cardiopulmonary bypass surgery
6e), suggesting a disturbance in mitochondrial ATP generation
it is a measurable, physical degradation of the peripheral nervous system
Many of them experience a brief wisp of promise only to have it taken away. Even more promising is that FDA-approved MEK inhibitors already exist, potentially accelerating the path to clinical testing and improved patient outcomes